Skip to main content
Atrás
Watch Compare

Accustem Sciences Inc.

Calidad de datos: 83%
ACUT
OTC Manufacturing Chemicals
$0.27
▼ $0.02 (-5.36%)
Cap. Mercado: 4.26 M
Precio
$0.27
Cap. Mercado
4.26 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -872,332.0

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio0.35
Interest CoverageN/A

Valoración

PE (TTM)
-2.64
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -2.6 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

No hay estimaciones futuras disponibles

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -1.61 M
ROE N/A ROA -101.28%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -872,332.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.35
Interest Coverage N/A Asset Turnover N/A
Working Capital -2.91 M Tangible Book Value -2.91 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.64 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -20.48%
Market Cap 4.26 M Enterprise Value 4.26 M
Per Share
EPS (Diluted TTM) -0.11 Revenue / Share N/A
FCF / Share -0.05 OCF / Share -0.05
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 54.05%
SBC-Adj. FCF -956,200 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue — — —
Net Income -1.51 M -2.05 M -3.75 M
EPS (Diluted) -0.13 -0.18 —
Gross Profit — — —
Operating Income -1.51 M -2.05 M -3.75 M
EBITDA — — —
R&D Expenses 138,324.0 139,663.0 266,933.0
SG&A Expenses — — —
D&A — — —
Interest Expense — — —
Income Tax — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 50,851.0 133,897.0 939,689.0
Total Liabilities 3.36 M 2.25 M 1.08 M
Shareholders' Equity -3.31 M -2.11 M -139,550.0
Total Debt — — —
Cash & Equivalents — — —
Current Assets 50,433.0 129,849.0 932,011.0
Current Liabilities 3.36 M 2.25 M 1.08 M